5.17
前日終値:
$5.14
開ける:
$5.15
24時間の取引高:
2.45M
Relative Volume:
0.62
時価総額:
$506.59M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+5.08%
1か月 パフォーマンス:
-11.32%
6か月 パフォーマンス:
+33.59%
1年 パフォーマンス:
+176.47%
Atyr Pharma Inc Stock (ATYR) Company Profile
名前
Atyr Pharma Inc
セクター
電話
(858) 731-8389
住所
10240 SORRENTO VALLEY ROAD, SAN DIEGO
ATYR を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ATYR
Atyr Pharma Inc
|
5.17 | 503.65M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Atyr Pharma Inc Stock (ATYR) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-02-18 | 開始されました | Leerink Partners | Outperform |
2025-01-06 | 開始されました | Cantor Fitzgerald | Overweight |
2024-10-04 | 開始されました | Wells Fargo | Overweight |
2024-09-05 | 開始されました | Jefferies | Buy |
2023-07-05 | ダウングレード | Oppenheimer | Outperform → Perform |
2021-10-12 | 開始されました | RBC Capital Mkts | Outperform |
2021-09-21 | 開始されました | Piper Sandler | Overweight |
2021-05-10 | 開始されました | Laidlaw | Buy |
2020-08-17 | アップグレード | H.C. Wainwright | Neutral → Buy |
2020-03-04 | 開始されました | ROTH Capital | Buy |
2020-03-02 | 開始されました | Oppenheimer | Outperform |
2018-02-14 | ダウングレード | JP Morgan | Neutral → Underweight |
2017-09-07 | 開始されました | Piper Jaffray | Overweight |
2016-12-13 | ダウングレード | JP Morgan | Overweight → Neutral |
2015-12-16 | 開始されました | Citigroup | Neutral |
2015-06-01 | 開始されました | Citigroup | Buy |
2015-06-01 | 開始されました | JP Morgan | Overweight |
すべてを表示
Atyr Pharma Inc (ATYR) 最新ニュース
Top chart patterns to watch in aTyr Pharma Inc.Trend Reversal & Entry and Exit Point Strategies - Newser
How to track smart money flows in aTyr Pharma Inc.Weekly Risk Report & Stepwise Entry/Exit Trade Alerts - Newser
Does aTyr Pharma Inc. qualify in momentum factor screeningFed Meeting & Proven Capital Preservation Methods - Newser
aTyr Pharma: Why My Playbook Says 'Wait, Then Act' (NASDAQ:ATYR) - Seeking Alpha
2 Small-Cap Biotech Stocks Well Positioned for a Breakout - Nasdaq
Technical analysis overview for aTyr Pharma Inc. stockMarket Performance Report & Stock Portfolio Risk Control - Newser
Live market analysis of aTyr Pharma Inc.2025 Earnings Impact & Step-by-Step Trade Execution Guides - Newser
aTyr Pharma Inc.’s volatility index tracking explainedMarket Sentiment Summary & Stepwise Entry/Exit Trade Alerts - Newser
Risk adjusted return profile for aTyr Pharma Inc. analyzedSell Signal & Safe Entry Trade Reports - Newser
How to escape a deep drawdown in aTyr Pharma Inc.Market Performance Summary & Real-Time Stock Entry Alerts - Newser
What data driven models say about aTyr Pharma Inc.’s futureMarket Growth Report & Daily Volume Surge Signals - Newser
Regression analysis insights on aTyr Pharma Inc. performanceJuly 2025 Sentiment & Weekly Market Pulse Alerts - Newser
Analyzing drawdowns of aTyr Pharma Inc. with statistical toolsMarket Growth Review & Capital Protection Trade Alerts - Newser
Developing predictive dashboards with aTyr Pharma Inc. dataJuly 2025 Market Mood & Fast Exit Strategy with Risk Control - Newser
Heatmap analysis for aTyr Pharma Inc. and competitorsLong Setup & Free Growth Oriented Trading Recommendations - Newser
Using fundamentals and technicals on aTyr Pharma Inc.Market Movement Recap & Fast Entry and Exit Trade Plans - Newser
Is aTyr Pharma Inc. stock bottoming outQuarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
What institutional flow reveals about aTyr Pharma Inc.July 2025 Big Picture & Smart Swing Trading Alerts - Newser
How to use a screener to detect aTyr Pharma Inc. breakouts2025 Year in Review & Expert-Curated Trade Recommendations - Newser
Applying Elliott Wave Theory to aTyr Pharma Inc.July 2025 Spike Watch & Stepwise Trade Signal Implementation - Newser
Published on: 2025-08-24 08:03:39 - Newser
Is aTyr Pharma Inc. exposed to political riskInsider Selling & High Yield Equity Trading Tips - theviewers.co.kr
Portfolio Recap: Is aTyr Pharma Inc. stock heavily shortedJuly 2025 PostEarnings & Daily Profit Maximizing Trade Tips - theviewers.co.kr
why atyr pharma inc. stock attracts strong analyst attention2025 Trading Recap & Consistent Growth Stock Picks - Newser
Traders Consider Averaging Down in aTyr Pharma Inc.Trade Entry Report & AI Powered Buy and Sell Recommendations - beatles.ru
What is aTyr Pharma Inc.’s book value per share2025 Geopolitical Influence & Entry and Exit Point Strategies - theviewers.co.kr
Nvidia To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Jefferies Updates aTyr Pharma (ATYR) Rating with Increased Price Target | ATYR Stock News - GuruFocus
aTyr Pharma Inc. At Critical Juncture — Bounce or BreakdownJuly 2025 Momentum & Community Verified Swing Trade Signals - beatles.ru
ATyr Pharma Rated as Overweight at Cantor Fitzgerald on Efzofitimod Expectations - MSN
Is it too late to sell aTyr Pharma Inc.Risk Management & Real-Time Buy Signal Alerts - Newser
Moving Average Crossover Confirms Uptrend in aTyr Pharma Inc.2025 Bull vs Bear & Stepwise Trade Execution Plans - beatles.ru
What makes aTyr Pharma Inc. stock price move sharplyNew Guidance & High Return Stock Watch Alerts - beatles.ru
High Growth US Tech Stocks To Watch In August 2025 - Yahoo Finance
RSI Crosses Above 30 for aTyr Pharma Inc. — Reversal in SightTrade Analysis Summary & Daily Stock Trend Reports - beatles.ru
aTyr Pharma: Estimating Their Phase 3 Lung Disease Trial Outcome (NASDAQ:ATYR) - Seeking Alpha
Atyr Pharma Inc (ATYR) 財務データ
Atyr Pharma Inc (ATYR) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):